Polar Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
$19M Sell
250,000
-255,000
-50% -$19.4M 0.14% 137
2020
Q2
$62.3M Buy
505,000
+305,000
+153% +$37.6M 0.54% 57
2020
Q1
$16.9M Buy
200,000
+80,000
+67% +$6.76M 0.18% 139
2019
Q4
$10.1M Sell
120,000
-5,000
-4% -$423K 0.09% 199
2019
Q3
$8.43M Buy
125,000
+10,000
+9% +$674K 0.08% 209
2019
Q2
$9.85M Hold
115,000
0.09% 192
2019
Q1
$10.2M Sell
115,000
-39,370
-26% -$3.5M 0.09% 181
2018
Q4
$13.1M Hold
154,370
0.14% 156
2018
Q3
$15M Sell
154,370
-57,130
-27% -$5.54M 0.13% 164
2018
Q2
$19.9K Sell
211,500
-800
-0.4% -$75 0.12% 155
2018
Q1
$17.2M Sell
212,300
-42,500
-17% -$3.45M 0.17% 148
2017
Q4
$22.7M Sell
254,800
-11,911
-4% -$1.06M 0.23% 122
2017
Q3
$24.8M Buy
266,711
+22,500
+9% +$2.09M 0.28% 111
2017
Q2
$22.2M Sell
244,211
-238,089
-49% -$21.6M 0.3% 112
2017
Q1
$42.3M Buy
482,300
+67,800
+16% +$5.95M 0.63% 47
2016
Q4
$34.3M Buy
414,500
+145,000
+54% +$12M 0.55% 47
2016
Q3
$24.9M Sell
269,500
-32,155
-11% -$2.97M 0.43% 70
2016
Q2
$23.5M Sell
301,655
-49,527
-14% -$3.85M 0.44% 72
2016
Q1
$29M Buy
351,182
+325,460
+1,265% +$26.8M 0.54% 51
2015
Q4
$2.7M Buy
25,722
+13,603
+112% +$1.43M 0.05% 203
2015
Q3
$1.28M Buy
12,119
+216
+2% +$22.7K 0.03% 237
2015
Q2
$1.63M Buy
11,903
+1,940
+19% +$265K 0.03% 235
2015
Q1
$1.24M Buy
9,963
+2,088
+27% +$260K 0.02% 245
2014
Q4
$712K Buy
7,875
+3,910
+99% +$354K 0.01% 247
2014
Q3
$286K Sell
3,965
-2,299
-37% -$166K 0.01% 259
2014
Q2
$390K Buy
+6,264
New +$390K 0.01% 252